Hyperprolactinemia Completed Phase 4 Trials for Aripiprazole (DB01238)

Also known as: Hyperprolactinemic disorder / Hyperprolactinaemia / Hyperprolactinemia (disorder)

IndicationStatusPhase
DBCOND0000952 (Hyperprolactinemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01085383Aripiprazole and Prolactin StudyTreatment